The Business Research Company’s report on the Amusement Parks Global Market Report 2025 Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
How are market drivers shaping the future growth trajectory of the adrenal cancer diagnostics industry?
The rising cigarette smoking is expected to propel the growth of the adrenal cancer diagnostics market going forward. Cigarette smoking refers to the act of inhaling and exhaling the fumes of burning tobacco, which contains nicotine, an addictive alkaloid that can have both stimulating and tranquilizing psychoactive effects. Cigarette smoking has been associated with an increased risk of adrenal cancer, including adrenal adenomas and adrenocortical carcinomas. The carcinogens in tobacco smoke can damage the DNA in adrenal cells, leading to mutations that can cause cancer. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Additionally, the total number of cigarettes sold rose 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the rising cigarette smoking is driving the growth of the adrenal cancer diagnostics market.
Adrenal Cancer Diagnostics Market Driver: Government Initiatives To Support Cancer
The government initiatives to support cancer is expected to propel the growth of the adrenal cancer diagnostics market going forward. Government initiatives refer to the significant increase in actions taken by a government to address and mitigate various challenges, issues, or crises. Government initiatives play a pivotal role in promoting early diagnosis, improving the quality and accessibility of diagnostic services, supporting research, and ultimately enhancing the effectiveness of adrenal cancer diagnostics. For instance, in April 2023, according to the NIH (National Institutes of Health), a US-based government agency responsible for biomedical and public health research, Biden-Harris administration established an initiative to decrease cancer-related deaths by 50% within the coming 25 years, while also enhancing the understanding and support for individuals enduring and surviving cancer. Therefore, the government initiatives to support cancer is driving the growth of the adrenal cancer diagnostics market going forward.
Access Your Free Sample of the Global Amusement Parks Global Market Report 2025 Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13242&type=smp
What is the estimated market size of the adrenal cancer diagnostics sector by 2029, based on current forecasts?
The adrenal cancer diagnostics market size has grown strongly in recent years. It will grow from $140.35 billion in 2024 to $149.96 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased incidence and awareness, genetic and molecular testing advances, biopsy techniques improvement, enhanced endocrine testing, integration of artificial intelligence (ai).
The adrenal cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $193.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to personalized medicine approaches, rise in minimally invasive procedures, telemedicine and remote consultations, liquid biopsy development, expanded genetic counseling services. Major trends in the forecast period include regulatory support for diagnostic innovations, digital pathology adoption, advancements in imaging technologies, liquid biopsy development, genomic profiling for precision medicine.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13242&type=smp
#Who are the top players in the adrenal cancer diagnostics market?
Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited
#What are the major trends in the adrenal cancer diagnostics market?
Major companies operating in the adrenal cancer diagnostics market are developing innovative initiatives with advanced collaboration models, such as the CancerX Startup Accelerator, to enhance digital innovations in cancer care. The Accelerator aims to provide promising startups with mentorship, training, and direct access to key players in the healthcare industry, including providers and pharmaceutical companies. For instance, in November 2023, CanceRx, LLC, a US-based public-private partnership to boost innovation in the fight against cancer, announced the launch of this initiative at the Future of Cancer Care Summit in Tampa, Florida. The program will select its inaugural cohort of approximately 15 to 20 companies starting in March 2024, focusing on critical themes like clinical research, screening, diagnosis, and treatment. It is expected to significantly advance the goals of the Cancer Moonshot initiative by addressing unmet needs in cancer care and fostering the development of effective digital health tools in oncology.
Which geography holds the highest adrenal cancer diagnostics market share?
North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/adrenal-cancer-diagnostics-global-market-report
How do different segments contribute to the overall expansion of the adrenal cancer diagnostics market?
The adrenal cancer diagnostics market covered in this report is segmented –
1) By Test: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-ray, Positron Emission Tomography (PET) Scan, Biopsy
2) By Treatment: Surgery, Chemotherapy, Radiotherapy, Targeted Cancer Therapies, Other Treatments
3) By Tumor Type: Pheochromocytoma, Adrenal Cortical Carcinoma, Other Types
4) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI, Functional MRI
2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT, Abdomen And Pelvis CT Scans
3) By X-ray: Standard X-ray Imaging, Specialized X-ray Techniques
4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans, Standalone PET Scans
5) By Biopsy: Fine Needle Aspiration Biopsy (FNA), Core Needle Biopsy, Surgical Biopsy
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13242
What defines the structure and scope of the adrenal cancer diagnostics market?
Adrenal cancer diagnostics refers to the process of identifying and diagnosing adrenal cancer, which is cancer that originates in the adrenal glands located above the kidneys. This process involves a series of medical evaluations, tests, and procedures designed to determine whether a person has adrenal cancer. It is essential for effective treatment planning and management.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
